Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
34.70
-1.16 (-3.23%)
At close: Aug 15, 2025, 12:52 PM
-3.23% (1D)
| Bid | 34.55 |
| Market Cap | 214.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.32B |
| EPS (ttm) | -3.84 |
| PE Ratio (ttm) | -9.04 |
| Forward PE | -10.76 |
| Analyst | Buy |
| Ask | 35.3 |
| Volume | 7,575 |
| Avg. Volume (20D) | 38,174 |
| Open | 34.25 |
| Previous Close | 35.86 |
| Day's Range | 34.03 - 36.14 |
| 52-Week Range | 2.15 - 54.30 |
| Beta | 1.06 |
About MNPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MNPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MNPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
+14.55%
Monopar Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+7%
Monopar Therapeutics shares are trading higher after the company announced it will join the Russell 3000 index.
